Published in Am J Pathol on November 01, 1995
Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation. Mol Biol Cell (1999) 1.11
Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol (1997) 0.82
Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells. Br J Pharmacol (2012) 0.78
Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells. Biochem J (1999) 0.76
The progression of renal disease. N Engl J Med (1988) 2.70
Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition. Proc Natl Acad Sci U S A (1987) 2.27
Physiology of the mesangial cell. Physiol Rev (1989) 2.13
Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol (1992) 2.08
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J (1990) 1.85
The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol (1987) 1.80
Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci (1991) 1.57
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol (1991) 1.41
Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem (1991) 1.38
Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev (1990) 1.35
The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol (1991) 1.29
Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases. Proc Natl Acad Sci U S A (1987) 1.26
Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl (1993) 1.22
Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. Kidney Int (1991) 1.22
The pathobiology of the mesangium. Kidney Int (1992) 1.17
Mesangial cell turnover: effect of heparin and peptide growth factors. Lab Invest (1991) 1.11
Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms. J Cell Physiol (1992) 1.10
Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest (1992) 1.09
Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol (1991) 1.07
Cytokines and mesangial cells. Kidney Int Suppl (1993) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int (1990) 1.00
The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin Investig (1992) 0.99
Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol Endocrinol (1992) 0.99
Cell-type-specific nuclear translocation of fibroblast growth factor-2 isoforms during chicken kidney and limb morphogenesis. Dev Biol (1994) 0.98
Regulation of mesangial cell proliferation. Am J Kidney Dis (1991) 0.97
Complete sequence of a human receptor for acidic and basic fibroblast growth factors. Nucleic Acids Res (1990) 0.95
Basic fibroblast growth factor in the early human burn wound. J Surg Res (1994) 0.93
Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells. J Cell Physiol (1991) 0.88
Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas. J Clin Endocrinol Metab (1992) 0.83
The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J (1999) 5.47
Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem J (1989) 2.85
Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol (1999) 2.39
VEGF(165) mediates glomerular endothelial repair. J Clin Invest (1999) 2.18
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int (2000) 1.79
Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant (2007) 1.63
The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem (1997) 1.62
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
Isolation and characterization of lymphocyte plasma membranes. Biochim Biophys Acta (1972) 1.54
The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol (1992) 1.44
The NF-kappa b repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kappa b-flanking sequence element. J Biol Chem (2000) 1.44
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int (1996) 1.43
[Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients?]. Dtsch Med Wochenschr (2007) 1.43
Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung (1994) 1.43
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol (1999) 1.42
Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41
Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm. Neurosurgery (1988) 1.39
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (1991) 1.39
Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem (1991) 1.38
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol (1994) 1.33
TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol (1989) 1.32
Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol (1993) 1.30
Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol (1987) 1.30
Interleukin 1: more than a mediator between leukocytes. Trends Pharmacol Sci (1988) 1.30
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations. Eur J Immunol (1972) 1.27
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24
Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24. Clin Nephrol (2009) 1.18
Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br J Pharmacol (1989) 1.17
The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. J Immunol (1978) 1.17
Rodent models of nephropathy associated with type II diabetes. J Nephrol (1999) 1.17
Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin Nephrol (1997) 1.14
Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int (1997) 1.14
Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J Immunol (1986) 1.13
Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol (2000) 1.12
Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney Int (1997) 1.11
Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-alpha 1. J Immunol (1989) 1.11
The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem (2000) 1.10
Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int (2006) 1.10
Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biol Chem (1988) 1.10
Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol (1989) 1.09
Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J Biol Chem (1998) 1.08
Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol (1991) 1.07
Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int (1995) 1.07
Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis. J Am Soc Nephrol (2001) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Biol Chem Hoppe Seyler (1990) 1.05
Modulation of enzyme activities in isolated lymphocyte plasma membranes by enzymatic modification of phospholipid fatty acids. J Biol Chem (1981) 1.05
Phospholipid metabolism of stimulated lymphocytes. Composition of phospholipid fatty acids. Biochim Biophys Acta (1975) 1.03
T-cell antigen receptor-induced signal-transduction pathways--activation and function of protein kinases C in T lymphocytes. Eur J Biochem (1995) 1.03
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J Immunol (1998) 1.02
Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol (1991) 1.02
Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli. Z Immunitatsforsch Immunobiol (1977) 1.01
Drugs which disrupt microtubules do not inhibit the initiation of lymphocyte activation. Nature (1977) 1.01
Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant (2000) 1.01
Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int (1990) 1.00
Interleukin-1-induced activation of a protein kinase co-precipitating with the type I interleukin-1 receptor in T cells. Eur J Immunol (1994) 1.00
Phospholipid metabolism of stimulated lymphocytes: activation of acyl-CoA:lysolecithin acyltransferases in microsomal membranes. Biochim Biophys Acta (1973) 0.99
The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin Investig (1992) 0.99
Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. Kidney Int (2006) 0.99
Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett (2000) 0.99
CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int (2007) 0.97
Regulation of mesangial cell proliferation. Am J Kidney Dis (1991) 0.97
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens (1994) 0.96
Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol (2001) 0.96
Quantitative determination of soluble and membrane proteins through their native fluorescence. Naturwissenschaften (1971) 0.96
Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells. Leuk Res (1991) 0.96
Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol (1993) 0.95
Induction of prostaglandin E release from macrophages by colchicine. J Immunol (1980) 0.95
Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukoc Biol (1994) 0.95
Activation of cloned human natural killer cells via Fc gamma RIII. J Immunol (1989) 0.93
Enhancement of the PGE1 response of macrophages by concanavalin A and colchicine. J Immunol (1977) 0.93
Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol (1994) 0.93
C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int (1998) 0.93
Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney Int (1997) 0.93
Differentiation and retrodifferentiation of U937 cells: reversible induction and suppression of intermediate filament protein synthesis. Eur J Cell Biol (1990) 0.93
Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus. Am J Kidney Dis (2001) 0.92
Antibody-mediated target cell lysis by nonimmune cells: the use of anti-immunoglobulin to distinguish effector cell population. J Immunol (1974) 0.92
Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol (1988) 0.92
Progression of diabetic nephropathy. Insights from cell culture studies and animal models. Kidney Blood Press Res (1999) 0.92
IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. Eur J Immunol (1998) 0.91
Phospholipid metabolism of stimulated lymphocytes. Effects of phytohemagglutinin, concanavalin A and anti-immunoglobulin serum. Eur J Biochem (1972) 0.91
Early changes in the phospholipid metabolism of lymphocytes following stimulation with phytohemagglutinin and with lysolecithin. Eur J Immunol (1971) 0.91
Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int (1997) 0.90
Interleukin-1-induced signaling in T-cells. Evidence for the involvement of phosphatases PP1 and PP2A in regulating protein kinase C-mediated protein phosphorylation and interleukin-2 synthesis. J Biol Chem (1993) 0.90